to the mind of the user, may also cause chromosomal abnormalities, foetal malformations, and possibly leukaemia.
These reports raise the question whether the screening of drugs introduced therapeutically or illegally is yet adequate. Is sufficient care being taken with a new drug to determine not only its teratogenic potential but also its potentialities as a chromosome-breaking agent and mutagen ? In-vitro techWniques are now sufficiently developed for these tests to be carried out. How many drugs in use today have similar effects to L.S.D. and how many have been tested ?
Getting on Their Nerves
It has recently been pointed out that about half of the cases of peripheral neuritis seen by the neurologist are of unknown aetiology.1 Drugs and poisons that may give rise to a neuropathy range from isoniazid prescribed by doctors to podophyllin (American mandrake) sold by herbalists to young women suffering from amenorrhoea. Acrylamide is a white crystalline solid with no significant volatility. As a biologically harmless polymer it is familiar to engineers and biochemists. The former waterproof soils with it so that tunnels may be constructed under rivers and mines sunk through water tables; biochemists use small quantities to separate proteins. In another form the polymer is used to flocculate particles so that, for example, the same water may wash successive heaps of coal. The users of the polymer are safe and so are those who make the polymer from acrylamide under reasonably good hygienic conditions. However, when the men handling the white acrylamide powder in large bags work under poor conditions where they cannot carry out simple measures of personal hygiene, an insidious condition can develop which neither they nor their family doctors may recognize as being a result of the work they are doing. Indeed, one case of acrylamide poisoning was recognized by Garland and Patterson only in a work-place as they watched the man trying to open a bag with his knife.
That work with acrylamide might produce a neuropathy had been suggested by the first scientific study of the compound by A. S. Kuperman.3 He drew attention to its extraordinary cumulative action, for in cats it could produce a similar condition whether it was given as a single dose of 50 mg./kg. body weight or 50 daily doses of 1 mg./kg. This chronic cumulative effect has since been shown to occur in other species.4 5 Detailed studies of poisoned rats have shown the lesion to be a " dying back " process similar to that discussed by J. B. Cavanagh,6 and it is the large-diameter motor fibres that appear to be the most sensitive to the toxic effect of acrylamide.5 In rats doses spread over days or even weeks could eventually produce clinical evidence of neurological damage.5 Fortunately in man, as in animals, the condition is slowly reversible after exposure ceases, but it is not yet possible to say whether recovery will be complete in severely affected patients. While there is no information yet on the biochemical disturbances which this relatively simple compound produces in the nervous system, it seems likely that its mode of action will be studied in the hope that more will be learnt about the metabolic processes essential to the maintenance of healthy neurones.
If ever there was good experimental evidence to warn users that a substance might be a chronic cumulative poison, the case of acrylamide seems outstanding. Perhaps the principal manufacturers believed that everyone would use it with the care they had exercised in making it after they had encountered a few cases among their workers. Yet, notoriously with chemical poisoning, it is the user and not the maker who is liable to meet trouble. Garland and Patterson conclude that acrylamide poisoning " is a relatively easy hazard to contain." Not only have some users failed to contain the hazard but neither do they seem to have appreciated that the disability suffered by some of their employees handling the substance had resulted from exposure to it.
The immediate lesson of Garland and Patterson's report is that doctors should never fail to make detailed inquiries into the occupation of their patients who present with unusual illnesses, though clearly many cases of illness (for example, neuritis or leukaemia) that may be related to a man's work are not necessarily so. The point about acrylamide poisoning is that the clinical course is unusual compared, for instance, with the Guillain-Barre type of peripheral neuropathy.
Acrylamide poisoning has been seen in the U.S.A., and published accounts, referred to by Garland and Patterson, are available from Japan and Canada as well as Great Britain now. The main lesson to be learnt is that simple hygiene is essential in every chemical plant. In most cases this is all that is needed to prevent poisoning. When so much attention is paid to the establishment of magical figures known as M.A.C.s (maximum allowable concentrations) for atmospheric contaminants, surely employers in this country, which led the Industrial Revolution, might pioneer the Industrial Safety Revolution by providing the means and encouraging the discipline necessary for the protection of employees from injury. Leading Articles MEBDCOs is blamed. In some cases of primary dysmenorrhoea there may be psychogenic overlay or a low threshold of pain,' but this is probably not the whole explanation. J. Chassar Moir2 found that patients with dysmenorrhoea felt pain when the intrauterine pressure exceeded their own blood pressure. This ischaemic type of pain would be expected to last for longer than the duration of the single contraction of the uterus, and indeed the pain of dysmenorrhoea has two components: the colicky part due to contraction and the prolonged part due to ischaemia. Other theories of causation for primary dysmenorrhoea have been advanced. On the basis of histological studies of the endometrium the condition has been attributed to an iubalance in the oestrogen-progesterone equilibrium, but this has not been confirmed when assays of these hormones in the blood and urine of women with dysmenorrhoea have been done. It has also been postulated that an excess of progesterone could cause overdevelopment of the endometrium and also that progesterone causes high tone in the isthmus and upper part of the cervix. The belief that progesterone can cause dysmenorrhoea is strengthened by the fact that anovulatory cycles are painless. However, a progestational agent, dydrogesterone, has been shown3 4 to be effective in the relief of dysmenorrhoea, though it does not suppress ovulation.
A measure of our continuing inability to understand the mechanisms underlying primary dysmenorrhoea is reflected in the form of treatment in use. Among the many suggestions made recently by G. C. Schauffler' in a symposium on paediatric and adolescent gynaecology are physiotherapy, hot Sitz baths, and diathermy. He found exercise relatively valueless and hypnosis surprisingly effective. Schauffiler scorns the use of hormone therapy but still advocates dilatation, of the cervix without mentioning the possible risk of causing incompetence of the cervix.
Another approach to the problem has been made by N. L. Warren and R. W. Hawker,6 who found that blood obtained from girls suffering from dysmenorrhoea contained lesi oxytocin than normal. They postulate that oxytocin has a regulatory function in the control of menstrual uterine contractions and that a low level of oxytocin could give rise to contractions associated with dysmenorrhoea. Certainly intramuscular injections of oxytocin have been shown to relieve dysmenorrhoea.7
The underlying cause of dysmenorrhoea remains obscure and treatment is variable. In the past it was believed that all that was required to prevent dysmenorrhoea was a "healthy outlook," plenty of exercise, and fresh air; and though this view has died out a healthy psychological outlook and attention to exercise and hygiene are nevertheless still important. When treatment with drugs is required it is usual first to try the effect of a simple analgesic such as aspirin, possibly combined with an antispasmodic, phenobarbitone, meprobamate, or amphetamine. If these relatively simple procedures are unsuccessful then recourse to hormone therapy is the next step. This can be done either by giving dydrogesterone 5 mg. b.d. from the fifth to the twenty-fifth day of the cycle or by using one of the contraceptive pills to suppress ovulation. Dilatation of the cervix is less commonly performed nowadays and the drastic approach of presacral neurectomy is fortunately very seldom if ever required now. It is important to avoid drugs with a potential for addiction. Each practitioner acquires his favourite forms of therapy and rings the changes as and when required, but the simplest and safest is best.
Nobody who reads last week's report' on the " brain drain" can doubt the validity of its conclusion: "This is now increasing to such an extent that it constitutes a threat to the interests of this country." A report by the Royal Society2 on the emigration of Ph.D.s evoked much the same comment in these columns3 four years ago, but in the interval more evidence has accumulated-and the emigration accelerated.
Though the present report excludes the medical and allied professions, it may be pertinent in several ways to the emigration of doctors, and the scientists whose departure it does discuss doubtless include among their numbers some whose work has a bearing on medicine. In round figures the numbers of engineers, technologists, and scientists emigrating for at least a year from the United Kingdom rose from 3,200 in 1961 to 6,200 in 1966 . Some will return, but the report holds out little hope that many will, for it goes so far as to state that " this trend could have disastrous consequences for British industry and the economy within ten to twenty years if it were to continue at the present rate." Though the emigration of scientists might be less disturbing in the short term than that of engineers and technologists, the report considers that in the long term "it throws light on attitudes which are developing and whose consequences could be serious for our capacity as a nation to hold our own in the advance of science-based industries.", It is not difficult to foresee that the development and practice bf medicine must likewise suffer great harm if the emigration of the profession's energetic and able younger men continues in the way it has done for some years.
Most of the emigrants go between the ages of 25 and 35, and since the report rightly excludes any idea of imposing restrictions to stop them it looks for reasons why these highly qualified people, exceptionally favoured to compete for professional advancement in their own country, make their career elsewhere (mostly in North/America). But since the motives for emigration are often complex and sometimes only half recognized by the emigrant himself any information obtained by questioning is apt to be difficult to interpret. According to the report North Amerca is thought of as a " young man's country " where ability counts more than age, experience, or seniority. The standard of living is attractive, and though British taxation as such is not believed to be a prime motive for leaving the country it is thought to have more influence in deterring emigrants from coming back.
What is believed to be a " cause of much malaise" is the 
